Australia markets open in 6 hours 47 minutes

Exopharm Limited (EX1.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0140+0.0010 (+7.69%)
At close: 03:17PM AEDT
Currency in AUD

Valuation measures4

Market cap (intra-day) 2.36M
Enterprise value 1.69M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.54
Enterprise value/revenue 16.92
Enterprise value/EBITDA -0.25

Trading information

Stock price history

Beta (5Y monthly) 1.21
52-week change 3-94.95%
S&P500 52-week change 3-14.12%
52-week high 30.3000
52-week low 30.0097
50-day moving average 30.0333
200-day moving average 30.0979

Share statistics

Avg vol (3-month) 3933.16k
Avg vol (10-day) 3998.09k
Shares outstanding 5177.72M
Implied shares outstanding 6N/A
Float 8100.63M
% held by insiders 147.62%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin -108.25%
Operating margin (ttm)-104.77%

Management effectiveness

Return on assets (ttm)-38.52%
Return on equity (ttm)-88.24%

Income statement

Revenue (ttm)6.4M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)4,356.50%
Gross profit (ttm)15.63k
Net income avi to common (ttm)-6.93M
Diluted EPS (ttm)-0.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.68M
Total cash per share (mrq)0.01
Total debt (mrq)1.59M
Total debt/equity (mrq)36.19
Current ratio (mrq)1.62
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-6.98M
Levered free cash flow (ttm)-5.85M